Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: A six-month randomized, partially double-blind, placebo-controlled comparative study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Giannaki, Christoforos D ^a,b,c   Sakkas, Giorgos K ^a,b   Karatzaferi, Christina ^a,b   Hadjigeorgiou, Georgios M ^a   Lavdas, Eleftherios ^a   Kyriakides, Theodoros ^d   Koutedakis, Yiannis ^a,b   Stefanidis, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^c UNIVERSITY OF NICOSIA   (Cyprus)

^d CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Extramyocellular lipids; Lean body mass; Muscle atrophy; Quality of life; Sleep

Indexed keywords

PLACEBO; ROPINIROLE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LEAN BODY WEIGHT; MALE; PHYSICAL PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SLEEP QUALITY; STUDY; UREMIA;

COMBINED MODALITY THERAPY; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; EXERCISE THERAPY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLACEBO EFFECT; QUALITY OF LIFE; RENAL DIALYSIS; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME; UREMIA;

EID: 84883652011     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-194     Document Type: Article

References (46)

1. The prevalence of symptoms in end-stage renal disease: a systematic review. Murtagh FE, Addington-Hall J, Higginson IJ, Adv Chronic Kidney Dis 2007 14 1 82 99 10.1053/j.ackd.2006.10.001 17200048 (Pubitemid 46014531)
2. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C, Mov Disord 2008 23 16 2267 2302 10.1002/mds.22254 18925578
3. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Trenkwalder C, Stiasny K, Pollmacher T, Wetter T, Schwarz J, Kohnen R, Kazenwadel J, Kruger HP, Ramm S, Kunzel M, et al. Sleep 1995 18 8 681 688 8560135
4. Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release. Pellecchia MT, Vitale C, Sabatini M, Longo K, Amboni M, Bonavita V, Barone P, Clin Neuropharmacol 2004 27 4 178 181 10.1097/01.wnf. 0000135480.78529.06 15319704 (Pubitemid 39121730)
5. Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome. Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Liakopoulos V, Tsianas N, Koukoulis GN, Koutedakis Y, Stefanidis I, PLoS One 2011 6 10 25180 10.1371/journal.pone.0025180 21984901
6. Anabolic and catabolic mechanisms in end-stage renal disease. Johansen KL, Adv Chronic Kidney Dis 2009 16 6 501 510 10.1053/j.ackd.2009.07.007 19801138
7. Augmentation as a treatment complication of restless legs syndrome: concept and management. Garcia-Borreguero D, Allen RP, Benes H, Earley C, Happe S, Hogl B, Kohnen R, Paulus W, Rye D, Winkelmann J, Mov Disord 2007 22 S18 476 S484 10.1002/mds.21610 17580331
8. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Lou JS, Kearns G, Benice T, Oken B, Sexton G, Nutt J, Mov Disord 2003 18 10 1108 1114 10.1002/mds.10505 14534913 (Pubitemid 37336933)
9. Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome. Giannaki CD, Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Patramani G, Lavdas E, Liakopoulos V, Koutedakis Y, Stefanidis I, ASAIO J 2010 56 6 538 542 10.1097/MAT.0b013e3181f1cc04 21245801
10. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Giannaki CD, Mertens PR, Rountas C, Vlychou M, Liakopoulos V, Stefanidis I, ASAIO J 2008 54 2 185 190 10.1097/MAT.0b013e3181641b07 18356653 (Pubitemid 351450764)
11. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Sleep Med 2003 4 2 101 119 10.1016/S1389-9457(03)00010-8 14592341 (Pubitemid 36527231)
12. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, Sleep Med 2003 4 2 121 132 14592342 (Pubitemid 36527232)
13. Heyward VH, Assessing cardiorespiratory fitness Champaign IL, USA: Human Kinetics 3 1998
14. Development of a walking test for the assessment of functional capacity in non-anaemic maintenance dialysis patients. Mercer TH, Naish PF, Gleeson NP, Wilcock JE, Crawford C, Nephrol Dial Transplant 1998 13 8 2023 2026 10.1093/ndt/13.8.2023 9719158 (Pubitemid 28356769)
15. Assessment and monitoring of physical function for people with CKD. Koufaki P, Mercer T, Adv Chronic Kidney Dis 2009 16 6 410 419 10.1053/j.ackd.2009.08.010 19801131
16. "Buffalo hump" in men with HIV-1 infection. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M, Lancet 1998 351 9106 867 870 10.1016/S0140-6736(97)11443-X 9525364 (Pubitemid 28121175)
17. The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M, Clin Infect Dis 2004 39 5 732 735 10.1086/422725 15356790 (Pubitemid 39180448)
18. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. Lee S, Kuk JL, Davidson LE, Hudson R, Kilpatrick K, Graham TE, Ross R, J Appl Physiol 2005 99 3 1220 1225 10.1152/japplphysiol.00053.2005 15860689 (Pubitemid 41214543)
19. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH, J Am Soc Nephrol 2001 12 12 2797 2806 11729250 (Pubitemid 33115428)
20. A self-rating depression scale. Zung WW, Arch Gen Psychiatry 1965 12 63 70 10.1001/archpsyc.1965.01720310065008 14221692
21. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Johns MW, Sleep 1991 14 6 540 545 1798888
22. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. Daugirdas JT, J Am Soc Nephrol 1993 4 5 1205 1213 8305648
23. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood. Montagna P, Hornyak M, Ulfberg J, Hong SB, Koester J, Crespi G, Albrecht S, Sleep Med 2011 12 1 34 40 10.1016/j.sleep.2010.08.005 20965780
24. Exercise and restless legs syndrome: a randomized controlled trial. Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B, J Am Board Fam Med 2006 19 5 487 493 10.3122/jabfm.19.5.487 16951298 (Pubitemid 44577207)
25. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. Fulda S, Wetter TC, Brain 2008 131 Pt 4 902 917 17932100 (Pubitemid 351499412)
26. The runner's high: opioidergic mechanisms in the human brain. Boecker H, Sprenger T, Spilker ME, Henriksen G, Koppenhoefer M, Wagner KJ, Valet M, Berthele A, Tolle TR, Cereb Cortex 2008 18 11 2523 2531 10.1093/cercor/bhn013 18296435
27. Effect of acute and chronic physical exercise on patients with periodic leg movements. Esteves AM, De Mello MT, Pradella-Hallinan M, Tufik S, Med Sci Sports Exerc 2009 41 1 237 242 10.1249/MSS.0b013e318183bb22 19092683
28. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, Happe S, Paulus W, Trenkwalder C, Brooks DJ, Brain 2005 128 Pt 4 906 917 15728657 (Pubitemid 40516927)
29. Long-term follow-up on restless legs syndrome patients treated with opioids. Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V, Wagner M, Sharma R, Hening W, Li L, Mov Disord 2001 16 6 1105 1109 10.1002/mds.1214 11748742 (Pubitemid 36041223)
30. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study. Walters AS, Ondo WG, Zhu W, Le W, J Neurol Sci 2009 279 1-2 62 65 19167016
31. Exercise and chronic kidney disease: current recommendations. Johansen KL, Sports Med 2005 35 6 485 499 10.2165/00007256-200535060-00003 15974634 (Pubitemid 41002969)
32. Body mass index, muscle and fat in chronic kidney disease: questions about survival. Mafra D, Guebre-Egziabher F, Fouque D, Nephrol Dial Transplant 2008 23 8 2461 2466 10.1093/ndt/gfn053 18390566
33. Atrophy of non-locomotor muscle in patients with end-stage renal failure. Sakkas GK, Ball D, Mercer TH, Sargeant AJ, Tolfrey K, Naish PF, Nephrol Dial Transplant 2003 18 10 2074 2081 10.1093/ndt/gfg325 13679483 (Pubitemid 37220314)
34. Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training. Sakkas GK, Sargeant AJ, Mercer TH, Ball D, Koufaki P, Karatzaferi C, Naish PF, Nephrol Dial Transplant 2003 18 9 1854 1861 10.1093/ndt/gfg237 12937235 (Pubitemid 37098559)
35. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T, J Am Soc Nephrol 2006 17 8 2307 2314 10.1681/ASN.2006010034 16825332 (Pubitemid 44141922)
36. Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. Samuels ER, Hou RH, Langley RW, Szabadi E, Bradshaw CM, J Psychopharmacol 2006 20 6 756 770 10.1177/ 0269881106060770 16401653 (Pubitemid 44622740)
37. Effect of diabetes mellitus on muscle size and strength in patients receiving dialysis therapy. Sakkas GK, Kent-Braun JA, Doyle JW, Shubert T, Gordon P, Johansen KL, Am J Kidney Dis 2006 47 5 862 869 10.1053/j.ajkd.2006.01. 013 16632026
38. Intramyocellular lipids and insulin resistance. Machann J, Haring H, Schick F, Stumvoll M, Diabetes Obes Metab 2004 6 4 239 248 10.1111/j.1462-8902. 2004.00339.x 15171747 (Pubitemid 38807797)
39. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, et al. J Clin Endocrinol Metab 2003 88 4 1785 1791 10.1210/jc.2002-021674 12679474 (Pubitemid 36623405)
40. Impact of end-stage renal disease and dialysis on glycemic control. Mak RH, Semin Dial 2000 13 1 4 8 10740665
41. Liver fat, visceral adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients. Sakkas GK, Karatzaferi C, Zintzaras E, Giannaki CD, Liakopoulos V, Lavdas E, Damani E, Liakos N, Fezoulidis I, Koutedakis Y, et al. Am J Physiol Regul Integr Comp Physiol 2008 295 6 1721 R1729 10.1152/ajpregu.00935.2007 18832089
42. Health-related quality of life in the era of erythropoietin. Weisbord SD, Kimmel PL, Hemodial Int 2008 12 1 6 15 10.1111/j.1542-4758.2008.00233.x 18271834 (Pubitemid 351247370)
43. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Montplaisir J, Karrasch J, Haan J, Volc D, Mov Disord 2006 21 10 1627 1635 10.1002/mds.21050 16874755 (Pubitemid 44742190)
44. Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis. Kawauchi A, Inoue Y, Hashimoto T, Tachibana N, Shirakawa S, Mizutani Y, Ono T, Miki T, Clin Nephrol 2006 66 6 440 446 17176916 (Pubitemid 44896153)
45. Depression in patients with end-stage renal disease treated with dialysis: has the time to treat arrived? Kimmel PL, Peterson RA, Clin J Am Soc Nephrol 2006 1 3 349 352 10.2215/CJN.00890306 17699229
46. Restless legs syndrome in end-stage renal disease. Gigli GL, Adorati M, Dolso P, Piani A, Valente M, Brotini S, Budai R, Sleep Med 2004 5 3 309 315 10.1016/j.sleep.2004.01.014 15165541 (Pubitemid 38684229)